Skip to main content

Cronos Group Inc.

CRON
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001656472

No open-market purchases or sales by Cronos Group Inc. insiders were filed in the last 90 days; 194 institutions reported holding it in 13F filings for Q2 2026, worth $133.7M in total; no superinvestor holds it.

Superinvestors holding CRON, Q2 2026

See all superinvestors

No superinvestor reported holding CRON in Q2 2026.